References
- Amir S. M., Osathanondh R., Berkowitz R. S., Goldstem D. P. Human chorionic gonadotrophin and thyroid function in patients with hydatidiform mole. American Journal of Obstetrics and Gynecology 1984; 150: 723–728
- Ho P. C., Wong L. C., Ma H. K. Plasma prolactin. progesterone, estradiol and human chorionic gonadotrophin in complete and partial moles before and after evacuation. Obstetrics and Gynecology 1986; 67: 99–106
- Howell R. J.S., Bolton A. E., Chard T. Placental protein 14 (PP 14) in late pregnancy. Archives of Gynecology 1986; 239: 27–29
- Julkunen M., Rutanen E-M., Koskimies A., Ranta Bohn T. H., Seppala M. Distribution of placental protein 14 in tissues and body fluids during pregnancy. British Journal of Obstetrics and Gynaecology 1985; 92: 1145–1151
- Norman R. J., Menabawey M., Lowing S. C., Buck R. H., Chard T. Relationship between blood and urine concentrations of intact human chorionic gonadotrophin and its free subunits in early pregnancy. Obstetrics and Gynecology 1987; 69: 590–593
- Szulman A. E., Surti U. The clinicopathologic profile of the partial hydatidiform mole. Obstetrics and Gynecology 1982; 59: 597–602
- Vejerslev L. O. Clinical management and diagnostic possibilities in hydatidiform mole with coexistent fetus. Obstetrical and Gynecological Survey 1991; 46: 577–588
- Wang H. S., Perry L. A., Kanisius J., Iles R. K., Holly J. M.P., Chard T. Purification and assay of insulin-like growth factor binding protein-1: measurement of circulating levels throughout pregnancy. Journal of Endocrinology 1991; 128: 161–168